锦欣生殖医疗集团有限公司（股票代码：01951）于2026年6月10日公告，披露当日于香港联交所场内回购7,996,000股普通股股份，约占紧接回购前已发行股本的0.30%。此次每股回购价格介乎每股2.15港元至2.20港元之间，合计支付金额17,411,290港元（约1,741.13万港元）。
公告显示，本次回购股份尚未注销，公司于2026年6月10日的已发行股本维持为2,705,044,043股，公司库藏股数量为零。根据2025年6月26日获股东大会通过的购回授权，公司可购回股份总数为274,470,604股。截至目前，公司合计已根据该授权在包括香港联交所在内的交易市场回购共106,572,000股，占授权通过日已发行股本总数约3.8828%。
公司同时确认，本次回购行为已遵守香港联交所证券上市规则及相关适用法律法规。公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.